Serum cytokine and T regulatory cell levels in patients with burning mouth syndrome

Journal of Oral Pathology and Medicine

Volumn 37, Issue 9, 2008, Pages 528-534

  Pekiner, Filiz Namdar ^a   Demirel, Gülderen Yanikkaya ^b   Gümrü, Birsay ^a   Özbayrak, Semih ^a  

^a MARMARA UNIVERSITY   (Turkey)

^b Centro Laboratories   (Turkey)

Author keywords

Burning mouth syndrome; Cytokine; Serum; T regulatory cell

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; TRANSCRIPTION FACTOR FOXP3; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ANXIETY; ARTICLE; BURNING MOUTH SYNDROME; CD4+ CD25+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; FEMALE; FLOW CYTOMETRY; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RATING SCALE; REGULATORY T LYMPHOCYTE; SCORING SYSTEM; VISUAL ANALOG SCALE;

ADULT; AGED; ANTIGENS, CD; ANXIETY DISORDERS; BURNING MOUTH SYNDROME; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; DEPRESSIVE DISORDER; FEMALE; HUMANS; INTERLEUKIN-2; MALE; MATCHED-PAIR ANALYSIS; MIDDLE AGED; REFERENCE VALUES; STATISTICS, NONPARAMETRIC; T-LYMPHOCYTES, REGULATORY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 51349146460     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2008.00668.x     Document Type: Article

References (43)

1. Albuquerque RJ, De Leeuw R, Carlson CR, Okeson JP, Miller CS, Andersen AH. Cerebral activation during thermal stimulation of patients who have burning mouth disorder: an fMRI study. Pain 2006 122 : 223 34.
2. Grushka M, Epstein JB, Gorsky M. Burning mouth syndrome. Am Fam Physician 2002 65 : 615 20.
3. Rhodus NL, Carlson CR, Miller CS. Burning mouth (syndrome) disorder. Quintessence Int 2003 34 : 587 93.
4. Al Quran FA. Psychological profile in burning mouth syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2004 97 : 339 44.
5. Femiano F, Gombos F, Esposito V, Nunziata M, Scully C. Burning mouth syndrome (BMS): evaluation of thyroid and taste. Med Oral Pathol Oral Cir Bucal 2006 11 : E22 5.
6. Guimaraes AL, De Sa AR, Victoria JM, De Fatima Correia-Silva J, Gomez MV, Gomez RS. Interleukin-1beta and serotonin transporter gene polymorphisms in burning mouth syndrome patients. J Pain 2006 7 : 654 8.
7. Bergdahl M, Bergdahl J. Burning mouth syndrome: prevalence and associated factors. J Oral Pathol Med 1999 28 : 350 4.
8. Hakeberg M, Berggren U, Hagglin C, Ahlqwist M. Reported burning mouth symptoms among middle-aged and elderly women. Eur J Oral Sci 1997 105 : 539 43.
9. Scala A, Checchi L, Montevecchi M, Marini I, Giamberardino MA. Update on burning mouth syndrome: overview and patient management. Crit Rev Oral Biol Med 2003 14 : 275 91.
10. Lamey PJ, Freeman R, Eddie SA, Pankhurst C, Rees T. Vulnerability and presenting symptoms in burning mouth syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2005 99 : 48 54.
11. Pekiner FN, Ozbayrak S, Canakci E. Burning mouth syndrome in patients wearing prosthesis: evaluation of type I and type II. The Pain Clinic 2005 17 : 269 73.
12. Boras VV, Brailo V, Lukac J, Kordic D, Blazic-Potocki Z. Salivary interleukin-6 and tumor necrosis factor-alpha in patients with burning mouth syndrome. Oral Dis 2006 12 : 353 5.
13. Jaaskelainen SK, Rinne JO, Forssell H, et al. Role of the dopaminergic system in chronic pain - a fluorodopa-PET study. Pain 2001 90 : 257 60.
14. Forssell H, Jaaskelainen S, Tenovuo O, Hinkka S. Sensory dysfunction in burning mouth syndrome. Pain 2002 99 : 41 7.
15. Kronfol Z, Remick DG. Cytokines and the brain: implications for clinical psychiatry. Am J Psychiatry 2000 157 : 683 94.
16. Simcic D, Pezelj-Ribaric S, Grzic R, Horvat J, Brumini G, Muhvic-Urek M. Detection of salivary interleukin 2 and interleukin 6 in patients with burning mouth syndrome. Mediators Inflamm 2006 2006 (1) : 54632.
17. Xia J, Lin M, Jin Z. Correlations among mood disorder, serum interleukin-2 and interleukin-6 in patients with burning mouth syndrome. Hua Xi Kou Qiang Yi Xue Za Zhi 2003 21 : 377 8.
18. Rhodus NL, Cheng B, Myers S, Bowles W, Ho V, Ondrey F. A comparison of the pro-inflammatory, NF-kappaB-dependent cytokines: TNF-alpha, IL-1-alpha, IL-6, and IL-8 in different oral fluids from oral lichen planus patients. Clin Immunol 2005 114 : 278 83.
19. Yamano S, Atkinson JC, Baum BJ, Fox PC. Salivary gland cytokine expression in NOD and normal BALB / c mice. Clin Immunol 1999 92 : 265 75.
20. + regulatory T cells. J Leukoc Biol 2006 80 : 458 70.
21. + natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol Rev 2006 212 : 8 27.
22. Eli I, Kleinhauz M, Baht R, Littner M. Antecedents of burning mouth syndrome (glossodynia) - recent life events vs. psychopathologic aspects. J Dent Res 1994 73 : 567 72.
23. Lamey PJ, Lamb AB. Prospective study of aetiological factors in burning mouth syndrome. Br Med J 1988 296 : 1243 6.
24. Scott J, Huskisson EC. Graphic representation of pain. Pain 1976 2 : 175 84.
25. Zung WW. A self-rating depression scale. Arch Gen Psychiatry 1965 12 : 63 70.
26. Sardella A, Lodi G, Demarosi F, Uglietti D, Carrassi A. Causative or precipitating aspects of burning mouth syndrome: a case-control study. J Oral Pathol Med 2006 35 : 466 71.
27. Lamey PJ, Lamb AB. The usefulness of the HAD scale in assessing anxiety and depression in patients with burning mouth syndrome. Oral Surg Oral Med Oral Pathol 1989 67 : 390 2.
28. Pedersen AML, Smidt D, Nauntofte B, Christiani CJ, Jerlang BB. Burning mouth syndrome: etiopathogenic mechanisms, symptomatology, diagnosis and therapeutic approaches. Oral Biosci Med 2004 1 : 3 19.
29. Mcquay HJ, Tramer M, Nye BA, Carroll D, Wiffen PJ, Moore RA. A systematic review of antidepressants in neuropathic pain. Pain 1996 68 : 217 27.
30. Maina G, Vitalucci A, Gandolfo S, Bogetto F. Comparative efficacy of SSRIs and amisulpride in burning mouth syndrome: a single-blind study. J Clin Psychiatry 2002 63 : 38 43.
31. Lauria G, Majorana A, Borgna M, et al. Trigeminal small-fiber sensory neuropathy causes burning mouth syndrome. Pain 2005 115 : 332 7.
32. Dantzer R. Cytokine-induced sickness behavior: mechanisms and implications. Ann N Y Acad Sci 2001 933 : 222 34.
33. Chen Q, Xia J, Lin M, Zhou H, Li B. Serum interleukin-6 in patients with burning mouth syndrome and relationship with depression and perceived pain. Mediators Inflamm 2007 2007 : 45327.
34. + immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med 1998 188 : 287 96.
35. + T cell suppressor function. J Immunol 2004 172 : 6519 23.
36. + T cells without reversing their suppressive function. J Immunol 2005 175 : 7332 40.
37. + T cells for IL-2 and exploit it for the induction of IL-10 production. Int Immunol 2005 17 : 279 88.
38. + T cells. Adv Immunol 2003 81 : 331 71.
39. Alegre ML, Frauwirth KA, Thompson CB. T-cell regulation by CD28 and CTLA-4. Nat Rev Immunol 2001 1 : 220 8.
40. + regulatory T cells in maintaining immunologic self-tolerance and preventing autoimmune disease. Curr Mol Med 2003 3 : 693 706.
41. + immunoregulatory T cells is antigen nonspecific. J Immunol 2000 164 : 183 90.
42. Salomon B, Bluestone JA. Complexities of CD28 / B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation. Annu Rev Immunol 2001 19 : 225 52.
43. + T cells depends on strength of the CD3 signal: critical role for IL-2. J Leukoc Biol 2006 80 : 66 74.